doi:10.1002/jor.20096 Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, Sikiric P
2021, Mar;12(2)
Safety considerations for GLP-1RA use Based on current data from clinical trials in MASLD and longer-term cohorts in T2DM and obesity, GLP-1RA is generally considered safe
Download the HPLC Analysis/Mass Spectrum This product should only be handled by qualified, and licensed professionals
Efficacy of Weight-loss A recent systematic review and a meta-analysis by Wong et al (2025) found that GLP-1 receptor agonists induced an additional 4.45 kilogram of weight loss over placebo based on 47 randomized control trials with a cohort of 23,244 patients
Suitable for individuals who need a less intensive, off-label weight management option